Burcon NutraScience (BU) AGM 2026 summary

Opening remarks and agenda

• Meeting opened with formalities, introduction of board members, and explanation of virtual meeting procedures.

• Agenda included formal business, CEO presentation, and Q&A session.

Board and executive committee updates

• Six directors nominated and elected for the ensuing year: Alan Chan, Peter Kappel, John Vassallo, James Peter Pekar, Philip Dowad, and Chris Bunio.

• Appreciation expressed for outgoing board members Jean McCaherty and Richard Nazur Jr.

Financial performance review

• Audited consolidated financial statements for the year ended March 31, 2026, presented.

• Sales for 2026 projected at CAD 6 million, with a CAD 10 million run rate by year-end.

• Cash flow positive status anticipated inside calendar 2027.

• Facility reliability issues caused short-term production delays, but solutions have been implemented.